Cue BiopharmaCUE
13F holders, Q1 2026 (March 31)2holders
$0.23avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Cue Biopharma Inc. (CUE) in their 13F filings. The largest holders were Tidemark, LLC ($345) and Advisory Services Network, LLC ($46).
- Company
- Cue Biopharma Inc.
- CUSIP
- 22978P205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $391 |
| Exits | 0 | $0 |
Ownership 2 holders
| Tidemark, LLC | 0.00% | New | 1,500 | $345 |
| Advisory Services Network, LLC | 0.00% | New | 200 | $46 |
"% of holder's portfolio" is CUE's weight in each manager's 13F, not the share of Cue Biopharma Inc. the manager owns.